Home
Tenaya Therapeutics

Tenaya Therapeutics Market Share Analysis for August 2026

Health > Biotechnology and Pharmaceuticals

Domaintenayatherapeutics.com

Year Founded2016

Employees51 - 200

Annual Revenue$15M - $25M

Tenaya Therapeutics

Tenaya Therapeutics (including company regionals)

tenayatherapeutics.com

See more website traffic and engagement information

Tenaya Therapeutics Revenue up to August 2026 is 15M - 25M

revenue generated by Tenaya Therapeutics top domains

Tenaya Therapeutics top domains revenue over 3 years

Revenue for Tenaya Therapeutics top domains

tenayatherapeutics.com15M - 25M

See more with Sales Intelligence

Total visits to Tenaya Therapeutics's top domains

Understand Tenaya Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

tenayatherapeutics.com5.4K

See more with Sales Intelligence

Avg. visit duration in Tenaya Therapeutics's top domains

Analyze Tenaya Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

tenayatherapeutics.com00:00:48

See more with Sales Intelligence

Avg. pageviews on Tenaya Therapeutics's top domains

See how Tenaya Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

tenayatherapeutics.com2.25

See more with Sales Intelligence

Tenaya Therapeutics top competitors by domain

Top similar sites in August 2026, ranked by their affinity

roosterbio.comCompany NameRoosterBioEmployees51 - 200HQUnited States, Maryland, FrederickAnnual revenue$10M - $15MTotal visits7.2KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Tenaya Therapeutics

These are the website technologies, by industry, used by Tenaya Therapeutics top domains

Payment & Currencies (8)

Cart Functionality

Advertising (4)

PubMatic

eCommerce (3)

WooCommerce

Social (3)

Instagram

More Technologies

9

See all

News & Signals from Tenaya Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTenaya Therapeutics attended event 28th Annual Global Investment Conference on Jun 2nd '26.SOUTH SAN FRANCISCO, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) - Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that Company management will host investor meetings at the upcoming H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14, 2026 and the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026.

NewsTenaya Therapeutics is developing TN-201 on Jun 1st '26.Tenaya Therapeutics is developing TN-201, an AAV9 gene therapy for MYBPC3-associated HCM.

NewsTenaya Therapeutics attended event Canaccord Genuity 46th Annual Growth Conference on Aug 11th '26.Tenaya Therapeutics to participate in the Canaccord Genuity 46th Annual Growth Conference.